L. Sheiner, B. Rosenberg, and K. Melmon, Modelling of individual pharmacokinetics for computer-aided drug dosage, Computers and Biomedical Research, vol.5, issue.5, pp.411-459, 1972.
DOI : 10.1016/0010-4809(72)90051-1

H. Wu, A. Ding, D. Gruttola, and V. , Estimation of HIV dynamic parameters, Statistics in Medicine, vol.17, issue.21, pp.2463-2485, 1998.
DOI : 10.1002/(SICI)1097-0258(19981115)17:21<2463::AID-SIM939>3.0.CO;2-A

H. Wu and A. Ding, Population HIV-1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials, Biometrics, vol.17, issue.2, pp.410-418, 1999.
DOI : 10.1111/j.0006-341X.1999.00410.x

H. Wu, Statistical methods for HIV dynamic studies in AIDS clinical trials, Statistical Methods in Medical Research, vol.14, issue.2, pp.171-192, 2005.
DOI : 10.1191/0962280205sm390oa

A. Ding and H. Wu, Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models, Biostatistics, vol.2, issue.1, pp.13-29, 2001.
DOI : 10.1093/biostatistics/2.1.13

H. Wu and A. Ding, Design of Viral Dynamic Studies for Efficiently Assessing Potency of Anti-HIV Therapies in AIDS Clinical Trials, Biometrical Journal, vol.21, issue.2, pp.175-196, 2002.
DOI : 10.1002/1521-4036(200203)44:2<175::AID-BIMJ175>3.0.CO;2-3

G. Pillai, F. Mentré, and J. Steimer, Non-Linear Mixed Effects Modeling ??? From Methodology and Software Development to Driving Implementation in Drug Development Science, Journal of Pharmacokinetics and Pharmacodynamics, vol.72, issue.6, pp.161-183, 2005.
DOI : 10.1007/s10928-005-0062-y

M. Lindstrom and D. Bates, Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-687, 1990.
DOI : 10.2307/2532087

S. Beal and L. Sheiner, NONMEM Users Guides. University of California, 1992.

J. Pinheiro and M. Bates, Mixed-Effects Models in S and S-Plus, 2000.
DOI : 10.1007/978-1-4419-0318-1

J. Pinheiro and D. Bates, Approximations to the log-likelihood function in the nonlinear mixed-effects model, Journal of Computational and Graphical Statistics, vol.4, pp.12-35, 1995.

E. Kuhn and M. Lavielle, Maximum likelihood estimation in nonlinear mixed effects models, Computational Statistics & Data Analysis, vol.49, issue.4, pp.1020-1038, 2005.
DOI : 10.1016/j.csda.2004.07.002

P. Girard and F. Mentré, A comparison of estimation methods in nonlinear mixed effects models using a blind analysis, Abstracts of the Annual Meeting of the Population Approach Group in Europe, 2005.

M. Al-banna, A. Kelman, and B. Whiting, Experimental design and efficient parameter estimation in population pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.46, issue.4, pp.347-360, 1990.
DOI : 10.1007/BF01062273

E. Jonsson, J. Wade, and M. Karlsson, Comparison of some practical sampling strategies for population pharmacokinetic studies, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.2, pp.245-263, 1996.
DOI : 10.1007/BF02353491

A. Atkinson and A. Donev, Optimum Experimental Design, 1992.
DOI : 10.1007/978-3-642-04898-2_434

E. Walter and L. Pronzato, Identification of Parametric Models from Experimental Data, 1997.

F. Mentré, A. Mallet, and D. Baccar, Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, pp.429-442, 1997.
DOI : 10.1093/biomet/84.2.429

S. Retout, F. Mentré, and R. Bruno, Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2639, 2002.
DOI : 10.1002/sim.1041

S. Retout and F. Mentré, Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.13, issue.2, pp.209-227, 2003.
DOI : 10.1081/BIP-100101009

J. Nedelman, On some ???disadvantages??? of the population approach, The AAPS Journal, vol.7, issue.2, pp.374-382, 2005.
DOI : 10.1208/aapsj070238

B. Green and S. Duffull, Prospective Evaluation of a D-Optimal Designed Population Pharmacokinetic Study, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.2, pp.145-161, 2003.
DOI : 10.1023/A:1024467714170

F. Mentré, C. Dubruc, and J. Thenot, Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.3, pp.299-319, 2001.
DOI : 10.1023/A:1011583210549

S. Retout and F. Mentré, Optimization of Individual and Population Designs Using Splus, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.417-443, 2003.
DOI : 10.1023/B:JOPA.0000013000.59346.9a

S. Duffull, S. Retout, and F. Mentré, The use of simulated annealing for finding optimal population designs, Computer Methods and Programs in Biomedicine, vol.69, issue.1, pp.25-35, 2002.
DOI : 10.1016/S0169-2607(01)00178-X

V. Fedorov, Theory of Optimal Experiments, 1972.

H. Wynn, Results in the construction of D-optimum experimental designs, Journal of the Royal Statistical Society B, vol.34, pp.133-147, 1972.

C. Han and K. Chaloner, D- and c-optimal designs for exponential regression models used in viral dynamics and other applications, Journal of Statistical Planning and Inference, vol.115, issue.2, pp.585-601, 2003.
DOI : 10.1016/S0378-3758(02)00175-1

D. Kang, J. Schwartz, and D. Verotta, A sample size computation method for non-linear mixed effects models with applications to pharmacokinetics models, Statistics in Medicine, vol.23, issue.16, pp.2551-2566, 2004.
DOI : 10.1002/sim.1695

D. Kang, J. Schwartz, and D. Verotta, Sample Size Computations for PK/PD Population Models, Journal of Pharmacokinetics and Pharmacodynamics, vol.29, issue.5-6, pp.685-701, 2005.
DOI : 10.1007/s10928-005-0078-3

I. Marschner, Design of HIV viral dynamics studies, Statistics in Medicine, vol.17, issue.21, pp.2421-2434, 1998.
DOI : 10.1002/(SICI)1097-0258(19981115)17:21<2421::AID-SIM930>3.0.CO;2-A

A. Samson, M. Lavielle, and F. Mentré, Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model, Computational Statistics & Data Analysis, vol.51, issue.3, pp.1562-1574, 2006.
DOI : 10.1016/j.csda.2006.05.007
URL : https://hal.archives-ouvertes.fr/inserm-00182360

T. Louis, Finding the observed information matrix when using the EM algorithm, Journal of the Royal Statistical Society B, vol.44, pp.226-233, 1982.

J. Kiefer and J. Wolfowitz, Optimum Designs in Regression Problems, The Annals of Mathematical Statistics, vol.30, issue.2, pp.271-294, 1959.
DOI : 10.1214/aoms/1177706252

A. Mallet, A maximum likelihood estimation method for random coefficient regression models, Biometrika, vol.73, issue.3, pp.645-656, 1986.
DOI : 10.1093/biomet/73.3.645

A. Neumann, N. Lam, and H. Dahari, Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon- Therapy, Science, vol.282, issue.5386, pp.103-107, 1998.
DOI : 10.1126/science.282.5386.103

H. Wu, Y. Huang, and E. Acosta, Modeling Long-Term HIV Dynamics and Antiretroviral Response, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.39, issue.3, pp.272-283, 2005.
DOI : 10.1097/01.qai.0000165907.04710.da